Prev：Combination of PARP inhibitor and CDK4/6 inhibitor modulates cGAS/STING‐dependent therapy‐induced senescence and provides “one‐two punch” opportunity(A25012-6)
Next：Combinatorial leaky probiotic for anticancer immunopotentiation and tumor eradication.(KTA1020-12)
